Researchers at Tokyo Medical and Dental University (TMDU) have established a method to increase the released lentiviral particles produced by host cells, which will aid the use of the vectors for introducing foreign genes into cells
Tokyo, Japan - The introduction of foreign genes into cells has a range of benefits, such as compensating for dysfunctional genes in the cells and producing large amounts of specific gene products, and so they can be harvested and used clinically. Viruses are useful tools for this purpose, as they have evolved to enter cells and express their genetic material there. However, it has been difficult and expensive to produce lentiviral vectors in sufficient quantities to apply this approach in various contexts.
In a new study by a team based at Tokyo Medical and Dental University (TMDU), researchers have managed to boost the production and release of lentiviral particles from host cells by introducing two molecules into the viral culture. The findings should promote the use of lentiviral vectors for introducing exogenous genes into cells in a safe and efficient manner.
Viruses contain only a limited amount of genetic material, so they need to enter cells and hijack some of their hosts' machinery in order to survive and reproduce. In this latest work reported in the journal Scientific Reports, the team focused on some of the molecules that, when present in the host, can help viruses to do this, in this case for the HIV-1 virus.
"We first focused on the effects of the SPSB proteins, by expressing them in human embryonic kidney cells along with a plasmid for HIV-1," Shoji Yamaoka says. "SPSB1, but not SPSB2 and 3, boosted the release of HIV-1 from these cells, which was revealed by increased viral infection of indicator cells that exhibited bioluminescence upon infection."
The TMDU team then looked in detail at the mechanism behind this effect of SPSB1. Their findings showed that it activates a promoter in the HIV-1 genome to induce the transcription of the structural components that this virus uses to replicate. This in turn led the team to identify the Tax protein as another enhancer of virus production, given that it activates transcription factors that are also promoted by SPSB1. When Tax was co-expressed, virus production was boosted by up to 12 times.
"It is often difficult to produce enough virus to achieve gene transfer at a high enough rate, especially for transfer in vivo or in non-dividing cells," lead author Naoto Suzuki says. "This new approach of promoter activation using should extend the range of applications in which viral vectors can be used."
The article, "Robust Enhancement of Lentivirus Production by Promoter Activation," was published in Scientific Reports at doi: 10.1038/s41598-018-33042-5.
Source: Tokyo Medical and Dental University
Gag Order Puts Public Health at Risk, APIC Urges Immediate Action
February 4th 2025APIC warns that the HHS gag order on CDC communications endangers public health, delaying critical infection updates and weakening outbreak response amid rising tuberculosis, avian flu, Ebola, and measles threats.
Breaking Barriers: The Future of HIV Prevention and the Fight for Widespread PrEP Access
January 31st 2025Despite medical advances, HIV prevention faces roadblocks—low PrEP adoption, stigma, and accessibility issues threaten progress. Experts push for innovative, long-acting solutions to end the epidemic.
The Hidden Dangers of Hospital Ventilation: Are We Spreading Viruses Further?
January 31st 2025New research reveals hospital ventilation and air purifiers may unintentionally spread viral particles, increasing infection risks. Infection preventionists must rethink airflow strategies to protect patients and staff.